Shattuck Labs, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Shattuck Labs, Inc. | STTK - NASDAQ |
$14.00-$16.00 | $17.00 | $22.10 | 11.9 million | 10/9/2020 |
| Citigroup, Cowen, Evercore ISI | ||||||
Co-Manager(s): Needham & Co. | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-09-18 Terms Added 2020-10-05 | ||||||
Shattuck Labs, Inc. Quote & Chart - Click for current quote - STTK
IPO Boutique aggregates information on public companies and private companies, such as "STTK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Shattuck Labs, Inc. (adapted from Shattuck Labs, Inc. prospectus):
They are an innovative clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are an innovative clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "STTK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.